Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$278K Sell
4,556
-3,924
-46% -$238K 0.04% 480
2017
Q2
$519K Sell
8,480
-7,521
-47% -$458K 0.07% 409
2017
Q1
$970K Sell
16,001
-9,700
-38% -$588K 0.19% 214
2016
Q4
$1.44M Sell
25,701
-4,610
-15% -$270K 0.34% 68
2016
Q3
$1.8M Buy
30,311
+24,519
+423% +$1.43M 0.38% 41
2016
Q2
$318K Sell
5,792
-19,536
-77% -$1.04M 0.08% 427
2016
Q1
$1.28M Sell
25,328
-5,802
-19% -$284K 0.34% 78
2015
Q4
$1.57M Sell
31,130
-14,738
-32% -$743K 0.45% 22
2015
Q3
$2.16M Sell
45,868
-95,964
-68% -$5.1M 0.5% 8
2015
Q2
$7.71M Buy
141,832
+76,262
+116% +$4.28M 0.98% 4
2015
Q1
$3.6M Buy
65,570
+25,110
+62% +$1.42M 0.5% 58
2014
Q4
$2.19M Buy
+40,460
New +$2.25M 0.44% 71

Other funds holding MRK

GAM Systematic's MRK Position: Q3 2017 in Review

GAM Systematic reduced its Merck (MRK) stake by 46% in Q3 2017, selling an estimated $238K and leaving 4,556 shares worth $278K. The position accounts for 0.04% of the portfolio, ranked #480.

GAM Systematic first reported a position in MRK in Q4 2014 and has held it in 12 quarters since. The position peaked at $7.71M in Q2 2015. 1,923 funds tracked by Wall St. Rank hold MRK as of Q3 2017.

  • GAM Systematic held 4,556 shares of Merck worth $278K as of Q3 2017.
  • GAM Systematic sold 3,924 Merck shares in Q3 2017, an estimated $238K.
  • Merck made up 0.04% of GAM Systematic's portfolio in Q3 2017, its #480 holding.
  • GAM Systematic first reported a position in Merck in Q4 2014 and has held it in 12 quarters since.
  • GAM Systematic's Merck position peaked at $7.71M in Q2 2015.
  • 1,923 funds tracked by Wall St. Rank held Merck as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.